Principal Financial Group Inc. raised its holdings in Novanta Inc. (NASDAQ:NOVT – Get Rating) by 0.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 140,835 shares of the technology company’s stock after buying an additional 672 shares during the period. Principal Financial Group Inc.’s holdings in Novanta were worth $19,135,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Ellevest Inc. raised its stake in Novanta by 50.3% in the fourth quarter. Ellevest Inc. now owns 254 shares of the technology company’s stock valued at $35,000 after buying an additional 85 shares during the period. GHP Investment Advisors Inc. acquired a new position in shares of Novanta in the third quarter valued at approximately $32,000. UBS Group AG grew its position in shares of Novanta by 85.7% in the third quarter. UBS Group AG now owns 544 shares of the technology company’s stock valued at $63,000 after purchasing an additional 251 shares during the last quarter. Point72 Hong Kong Ltd grew its position in shares of Novanta by 350.6% in the third quarter. Point72 Hong Kong Ltd now owns 793 shares of the technology company’s stock valued at $92,000 after purchasing an additional 617 shares during the last quarter. Finally, Lazard Asset Management LLC grew its position in shares of Novanta by 23.1% in the first quarter. Lazard Asset Management LLC now owns 976 shares of the technology company’s stock valued at $138,000 after purchasing an additional 183 shares during the last quarter. Institutional investors own 97.55% of the company’s stock.
Novanta Trading Down 0.9 %
Shares of NASDAQ:NOVT opened at $166.37 on Monday. The company has a market capitalization of $5.96 billion, a P/E ratio of 81.16 and a beta of 1.30. Novanta Inc. has a 1 year low of $110.84 and a 1 year high of $173.10. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.84 and a quick ratio of 1.67. The business’s 50 day simple moving average is $155.89 and its 200 day simple moving average is $153.09.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on NOVT shares. Robert W. Baird upped their target price on Novanta from $150.00 to $161.00 in a research report on Thursday, May 11th. StockNews.com downgraded Novanta from a “buy” rating to a “hold” rating in a research report on Saturday.
Novanta Company Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
- Get a free copy of the StockNews.com research report on Novanta (NOVT)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Get Rating).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.